[HTML][HTML] Unexplained Causes of Glioma-Associated Epilepsies: A Review of Theories and an Area for Research

M Saviuk, E Sleptsova, T Redkin, V Turubanova - Cancers, 2023 - mdpi.com
Simple Summary Patients with gliomas experience worsened quality of life due to epileptic
attacks. Over 80% of patients are susceptible to seizures, significantly hindering their …

Targeting the p53 signaling pathway in cancers: molecular mechanisms and clinical studies

J Shen, Q Wang, Y Mao, W Gao, S Duan - MedComm, 2023 - Wiley Online Library
Tumor suppressor p53 can transcriptionally activate downstream genes in response to
stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis …

[HTML][HTML] Salvigenin suppresses hepatocellular carcinoma glycolysis and chemoresistance through inactivating the Pi3K/Akt/Gsk-3Β pathway

H Shao, J Chen, A Li, L Ma, Y Tang, H Chen… - Applied Biochemistry …, 2023 - Springer
Abstract Salvigenin is a Trimethoxylated Flavone enriched in Scutellariae Barbatae Herba
and Scutellariae Radix and is demonstrated to have anti-tumor properties in colon cancer …

[HTML][HTML] Current state of immune checkpoints therapy for glioblastoma

H Wang, J Yang, X Li, H Zhao - Heliyon, 2024 - cell.com
Glioblastoma (GBM), one of the most aggressive forms of brain cancer, has limited treatment
options. Recent years have witnessed the remarkable success of checkpoint inhibitor …

[HTML][HTML] Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer

H Su, C Peng, Y Liu - Frontiers in Cell and Developmental Biology, 2024 - frontiersin.org
The global challenge posed by cancer, marked by rising incidence and mortality rates,
underscores the urgency for innovative therapeutic approaches. The PI3K/Akt signaling …

PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation

S Rezaei, N Nikpanjeh, A Rezaee, S Gholami… - European Journal of …, 2023 - Elsevier
In addition to environmental conditions, lifestyle factors, and chemical exposure, aberrant
gene expression and mutations involve in the beginning and development of urological …

[HTML][HTML] Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma

T Guo, C Wu, J Zhang, J Yu, G Li, H Jiang… - Cell Communication and …, 2023 - Springer
Background Glioblastoma multiforme (GBM) is a devastating disease that lacks effective
drugs for targeted therapy. Previously, we found that the third-generation epidermal growth …

[HTML][HTML] Fibronectin type III domain containing 3B as a potential prognostic and therapeutic biomarker for glioblastoma

H Kwon, M Yun, TH Kwon, M Bang, J Lee, YS Lee… - Biomedicines, 2023 - mdpi.com
Glioblastoma (GBM) is a representative malignant brain tumor characterized by a dismal
prognosis, with survival rates of less than 2 years and high recurrence rates. Despite …

High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas

A Kone, A Ghouzlani, A Qandouci… - Frontiers in …, 2024 - frontiersin.org
Introduction Gliomas represent the most prevalent and aggressive tumors within the central
nervous system. Despite the current standard treatments, the median survival time for …

Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy

K Hushmandi, B Einollahi, SH Saadat, EHC Lee… - Molecular …, 2024 - Elsevier
Solute carrier (SLC), a diverse family of membrane proteins, are instrumental in
orchestrating the intake and efflux of nutrients including amino acids, vitamins, ions …